Journals / Türk Geriatri Dergisi / 2013 / Cilt: 16 - Sayı: 1

İz sürme testi: türk alzheımer tipi demans hastaları için yordayıcı geçerlik çalışması

Traıl makıng test: predıctıve valıdıty study on turkısh patıents wıth alzheımer dementıa

Pages
69–76
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our results were in accordance with related literature, and revealed that the TMT is a valid a psychometric instrument in assessing Turkish AD patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The Trail Making Test is a widely used test that assesses executive functions such as visual tracking, psychomotor speed, complex attention and mental flexibility.
📊
Key Findings & Data:The main aim of this study is to evaluate the validity of the TMT in AD patients.Materials and Method: The study group covers 50 subjects with AD and 50 healthy subjects.
💡
Conclusion & Impact:Our results were in accordance with related literature, and revealed that the TMT is a valid a psychometric instrument in assessing Turkish AD patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The Trail Making Test is a widely used test that assesses executive functions such as visual tracking, psychomotor speed, complex attention and mental flexibility. The main aim of this study is to evaluate the validity of the TMT in AD patients.Materials and Method: The study group covers 50 subjects with AD and 50 healthy subjects. The mean age was 73.98 years in AD group and 74.74 years in control group. The mean scores that were obtained from 8 subscores of the TMT were compared between both groups.Results: The TMT Time A, Time B, Time A+B, Time B-A, Correction B, Error A and Error B scores were significantly different between two groups. The estimated cut-off values for Time A, Time B, Time A+B, and Time B-A are 108 sec, 240 sec, 356 sec, and 112 sec, respectively.Conclusion: It is known that both parts of TMT are sensitive to progressive cognitive decline. It is suggested that Part A and B may differentiate demented from normal persons and Part B may detect early stages of the AD. Our results were in accordance with related literature, and revealed that the TMT is a valid a psychometric instrument in assessing Turkish AD patients.

Özet

Giriş: İz Sürme Testi (İST) görsel iz sürme, psikomotor hız, karmaşık dikkat ve zihinsel esneklik gibi yönetici işlevleri değerlendirmede yaygın olarak kullanılan bir testtir. Bu çalışmanın temel amacı, İST'nin Alzheimer hastaları (AH) için geçerliğini değerlendirmektir.Gereç ve Yöntem: Çalışmaya 50 AH ile 50 sağlıklı yaşlı birey denek olarak katılmıştır. AH grubunun yaş ortalaması 73.98, sağlıklı yaşlı grubunun yaş ortalaması 74.74'dür. İki grup İST'den alınan 8 alt puan açısından karşılaştırılmıştır.Bulgular: İki grup, İST A Süre, B Süre, A+B Süre, B-A Süre, B Düzeltme, A Hata ve B Hata puanları açısından anlamlı düzeyde farklıdır. A Süre, B Süre, A+B Süre ve B-A Süre alt testleri için kesme değerleri sırasıyla 108 sn, 240 sn, 356 sn ve 112 sn olarak belirlenmiştir.Sonuç: İST'nin her iki bölümünün de ilerleyici bilişsel gerilemeye duyarlı olduğu bilinmektedir. Bölüm A ve Bölüm B sağlıklı yaşlıları demanslı bireylerden ayırdedebilirken; Bölüm B, AH'yi erken evrede belirleyebilmektedir. Elde edilen sonuçlar ilgili litertürü desteklemiş ve İST'nin Türk Alzheimer hastalarının değerlendirilmesinde kullanılabilecek, psikometrik açıdan geçerli bir araç olduğunu göstermiştir.

🔖

Cite This Article

CANGÖZ, B., DEMİRCİ, S., ULUÇ, S. (2022). İz sürme testi: türk alzheımer tipi demans hastaları için yordayıcı geçerlik çalışması. Türk Geriatri Dergisi, Cilt: 16 - Sayı: 1, 69–76. https://ajindex.com/articles/614240

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Spreen O, Strauss E. A compendium of neuropsychological tests: Administration, norms and commentary. New York: Oxford University Press, 1991, pp 98–121
  2. Bowie CR, Harvey PD. Administration and interpretation of the Trail Making Test. Nature Protocols 2006;1(5):2277-81. (PMID:17406468)
  3. Ivnik JR, Malec JF, Smith GE, Tangalos EG, Petersen RC. Neuropsychological tests norms about age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, STROOP, TMT, and JLO. The Clinical Neuropsychologist 1996;10:262-78
  4. Tombaugh TN. Trail Making Test A and B. Normative data stratified by age and education. Archieves of Clinical Neuropsychology 2004 Mar;19(2):203-14. (PMID:15010086)
  5. Steinberg BA, Breliauskas LA, Smith GE, Ivink RJ. Mayo’s older Americans normative studies: Age and IQ-adjusted norms for the Trail Making Test, The Stroop Test and controlled Oral Word Association Test. The Clinical Neuropsychologist 2005;19:329-77. (PMID:16120535)
  6. Davis A. The influence of age on Trail Making Test perform- ance. Journal of Clinical Psychology 1986;24:96-8. (PMID:5639473)
  7. Ruffolo LF, Guilmette TJ, Willis WG. Comparison of time and error rates on the Trail Making Test among patients with head injuries, experimental malingerers, patients with suspect effort on testing, and normal controls. The Clinical Neuropsychologist 2000;14:223-30. (PMID:10916197)
  8. Stuss DT, Bisschop SM, Alexander MP, Levine B, Izukawa D. The Trail Making Test: A study in focal lesion patients. Psychological Assessment 2001;13:230-9. (PMID:11433797)
  9. Albert MS, Blacker D. Mild cognitive impairment and demen- tia. Annual Review of Psychology 2006;2:379-88. (PMID:17716075)
  10. McKhann O, Drachman D, Folstein M, Katzman R, Price D, Stradian EM. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspcies of department of health and human services task force on Alzheimer’s disease. Neurology 1984;34:939-44. (PMID:6610841). 11.Duchek D, Balota DA. Failure to control prepotent pathways in early dementia of Alzheimer’s type: Evidence from dichotic listen- ing. Neuropsychology 2005;19(5):687-95. (PMID:16187887). 12.Baddely AD, Baddely HA, Bucks RS, Wilcock GK. Attentional control in Alzheimer’s disease. Brain 2011;124:14492-508. (PMID:11459742). 13.Meguro K, Constans JM, Shimada M, Yamaguchi S, Ishizaki J, Ish› H, Yamdori A, Sehita Y. Corpus callosum atrophy, white matter lession, and frontal executive dysfunction in normal agn- ing and Alzheimer’s dise